Peginterferon alfa-2b Pregnancy and Breast Feeding Warnings
Peginterferon alfa-2b is also known as: PegIntron
Overview
Do not use Peginterferon alfa-2b if you are pregnant. Do not become pregnant for 6 months after you stop treatment with Peginterferon alfa-2b . Use an effective form of birth control during treatment with Peginterferon alfa-2b and for 6 months after you stop treatment. If you think you may be pregnant, contact your doctor. You will need to discuss the benefits and risks of using Peginterferon alfa-2b while you are pregnant. It is not known if Peginterferon alfa-2b is found in breast milk. Do not breast-feed while taking Peginterferon alfa-2b .
Peginterferon alfa-2b Pregnancy Warnings
Peginterferon alfa-2b has been assigned to pregnancy category C by the FDA. When used with ribavirin, the combination therapy has been assigned to pregnancy category X by the FDA. Animal studies with non-pegylated interferon alfa-2b have revealed evidence of abortifacient effects. There are no controlled data in human pregnancy. Peginterferon should only be given during pregnancy when benefits outweigh risks.
The manufacturer states that the drug is recommended for use in fertile women only when they are using effective contraception during the treatment period.
Peginterferon alfa-2b Lactation Warnings
There are no data on the excretion of peginterferon alfa-2b into human milk. The manufacturer recommends that due to the potential for serious adverse reactions in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.
Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This drug information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information in contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.
